Levosimendan as a rescue adjunct in amlodipine intoxication

Middle East Journal of Anesthesiology

Volumn 20, Issue 6, 2010, Pages 869-872

  Teker, M Gökhan ^a   Özdemir, Haluk ^a   Saidoglu, Leyla ^a   Erkalp, Kerem ^a   Başaranoǧlu, Gökçen ^a  

^a VAKIF GUREBA HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE; ANTIDOTE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; CARDIOTONIC AGENT; CHARCOAL; CRYSTALLOID SOLUTIONS; DOPAMINE; HYDRAZONE DERIVATIVE; INSULIN; ISOTONIC SOLUTION; NORADRENALIN; PYRIDAZINE DERIVATIVE; SIMENDAN;

ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTOXICATION; STOMACH LAVAGE; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; AMLODIPINE; ANTIDOTES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHLORIDE; CARDIOTONIC AGENTS; CHARCOAL; DOPAMINE; FEMALE; GASTRIC LAVAGE; HUMANS; HYDRAZONES; INSULIN; ISOTONIC SOLUTIONS; NOREPINEPHRINE; OVERDOSE; PYRIDAZINES; TREATMENT OUTCOME;

EID: 79955691557     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bruca DA, William TB: Amlodipine overdose causes prolongedcalcium channel blocker toxicity: Am J Emerg Med; 16:527-8, 1998.
2. Vogt S, Mehlig A, Hunziker: Survival of severe amlodipine intoxicarion due to medical intensive care. Forensic Sci Int; 161:216-20, 2006.
3. Katz AM: Cardiac ion channels: N Eng J Med; 328:1244-51, 1993.
4. Hockerman GH, Peterson BZ, Johnson BD, Catterall WA: Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol; 37:361-96, 1997.
5. Brunton LL, Lazo JS, Parker KL, Buxton IL, Blumenthal D, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th edition. New York, McGraw-Hill, 2005.
6. Ramoska EA, Spiller HA, Winter M, Borys D: A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med; 22:196-200, 1993.
7. Shepherd G, Klein-Schwartz W: High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother; 39:923-30, 2005.
8. Megarbane B, Karyo S, Baud FJ: The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning. Toxicol Rev; 23:215-22, 2004.
9. Smith SW, Ferguson KL, Hoffman RS, Nelson LS, Greller HA: Prolonged severe hypotension following combined amlodipine and valsartan ingestion. Clin Toxicol (Phil); 46:470-4, 2008.
10. Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI: Relative safety of hyperinsulinemia/euglycaemia therapy in the management of calcium channel blocker overdose:a prospective observational study. Intensive Care Med; 33:2019-24, 2007.
11. Lheureux PER, Zahir S, Gris M, Derrey AS, Penaloza A: Benchto- bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Critical Care; 10:212, 2006.
12. Harris NS: Case records of MassachusettsGeneral Hospital. Case 24-2006. A 40 year-old woman with hypotension after an overdose of amlodipine. N Eng J Med; 355:602-11, 2006.
13. Yuan TH, Kerns WP II, Tomaszewski CA, Ford MD, Kline JA: Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol; 36:463-74, 1999.
14. Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA: Insulin improves heart function and metabolism during nonischemic cardiogenic shock in awake canines. Cardiovasc Res; 34:289-98, 1997.
15. Whitlow PL, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Mantle JA, et al: Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Card; 49:811-20, 1982.
16. Rasmussen L, Husted SE, Johnsen SP: Severe intoxication after an intentional overdose of amlodipine Acta Anaesthesiol Scand; 47:1038-40, 2003.
17. Janion M, Stepien A, Sielski J, Gutkowski W: Is the Intra-aortic balloon pump a method of brain protection during cardiogenic shock after drug intoxication? J Emerg Med; Apr 8 (Epub ahead of print), 2008.
18. Ross FD: Calcium channel blockers. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Hoffman RS, Nelson RS, editors. Goldfrank's Toxicologic Emergencies, 7th edtion, New York, McGraw-Hill, pp. 762-74, 2002.
19. Salhanick SD, Shannon MW: Management of calcium channel antagonist overdose. Drug Saf; 26:65-79, 2003.
20. Buckley NA, Dawson AH, Howarth DM, Whyte IM: Slow release verapamil poisoning. Use of polyethylene glycol wholebowel lavage and high-dose calcium. Med J Aust; 158:202-4, 1993.
21. Buckley NA, Whyte IM, Dawson AH: Overdose with calcium channel blockers. BMJ; 308:1639, 1994.
22. Kenny J: Treating overdose with calcium channel blockers. BMJ; 308:992-3, 1994.
23. Ezidiegwu C, Spektor Z, Nasr MR, Kelly KC, Rosales LG: A case report on the role of plasma exchange in the management of massive amlodipine besylate intoxication. Ther Apher Dial; 12:180-4, 2008.
24. Humbert VH JR, Munn NJ, Hawkins RF: Noncardiogenic pulmonary edema complicating massive diltiazem overdose. Chest; 99:258-9, 1991.
25. Stanek EJ, Nelson CE, DeNofrio D: Amlodipine overdose. Ann Pharmacother; 31:853-6, 1997.
26. Toller WG, Stranz C: Levosimendan, a new inotropic and vasodilator agent. Anesthesiology; 104:556-69, 2006.
27. Perrone SV, Kaplinsky EJ: Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure. Int J Cardiol; 103:248-55, 2005.
28. Innes CA, Waqstaff AJ: Levosimendan: a review of its use in the management of acute decompansated heart failure. Drugs; 63:2651-71, 2003.